CMH fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Chordate Medical Holding AB is a medical technology company. It engages in the provision of developed, patented, and CE-marked product systems for neurostimulation treatment for the indications chronic migraine and chronic nasal congestion. The company was founded in February 2014 and is headquartered in Kista, Sweden.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
CMH does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company